B2DB — Who said what, where, and when

Aberrant T‑Cell Marker Expression in EBV Negative Plasmablastic Lymphoma in a Transplant Patient: Expanding an Unusual Immunophenotypic Spectrum

2026 ASCP/CAP-ACP Annual Meeting · 18 November 2026 · 12:00–12:45 · 517ABC - Exhibit Hall

Aberrant T‑Cell Marker Expression in EBV Negative Plasmablastic Lymphoma in a Transplant Patient: Expanding an Unusual Immunophenotypic Spectrum was a session at 2026 ASCP/CAP-ACP Annual Meeting on 18 November 2026 in Montreal, with 1 speaker on record.

Speakers